Stent tracking
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of arterial stents subject to tracking as part of approved premarket approval applications no longer are required to track the devices, FDA says in a letter sent to pertinent stent makers the week of Sept. 28